Skip to main content

Table 4 Antimicrobial activity (MIC and MBC in µg/mL) of synthesized compounds as well as reference antimicrobial drugs

From: Synthesis, characterization, and antibacterial activity studies of two Co(II) complexes with 2-[(E)-(3-acetyl-4-hydroxyphenyl)diazenyl]-4-(2-hydroxyphenyl)thiophene-3-carboxylic acid as a ligand

Coumpounds

Inhibition parameters

S. aureus ATCC25923

P. aeruginosa

E. coli ATCC25922

K. pneumoniae 22

7

MIC

MBC

MBC/CMI

32

 > 256

/

128

 > 256

/

64

 > 256

/

64

 > 256

/

11

MIC

MBC

MBC/CMI

32

 > 256

/

64

 > 256

/

64

 > 256

/

128

 > 256

/

12

MIC

MBC

MBC/CMI

128

 > 256

/

32

 > 256

/

 > 256

 > 256

/

64

 > 256

/

13

MIC

MBC

MBC/CMI

64

 > 256

/

64

 > 256

/

128

 > 256

/

64

 > 256

/

Reference drugs*

MIC

MBC

MBC/CMI

8

16

2

8

16

2

16

32

2

16

32

2

  1. / not determined, MIC Minimum Inhibitory Concentration, MBC Minimum Bactericidal Concentration
  2. *Ciprofloxacin was tested together with compounds 7, 11, 12 and 13